MeSH D029481 - chronic bronchitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Arformoterol | Arformoterol |  | 2021-11-09 |  |  |
| Glenmark Pharmaceuticals | Arformoterol | Arformoterol |  | 2021-06-22 |  |  |
| GSK | Umeclidinium, Fluticasone furoate, Vilanterol | Elebrato Ellipta |  | 2017-11-15 |  |  |
| Umeclidinium, Fluticasone furoate, Vilanterol | Temybric Ellipta |  | 2019-06-12 |  |  | |
| Umeclidinium, Fluticasone furoate, Vilanterol | Trelegy Ellipta | 2022-09-11 | 2017-09-18 |  |  | |
| Cipla | Arformoterol | Arformoterol |  | 2021-06-22 |  |  |
| Lupin Research | Arformoterol | Arformoterol |  | 2022-02-07 |  |  |
| Arformoterol | Brovana |  | 2006-10-06 |  |  | |
| Tiotropium | Tiotropium |  | 2023-06-20 |  |  | |
| Boehringer Ingelheim | Tiotropium | Spiriva | 2022-01-22 | 2004-01-30 |  |  |
| Olodaterol, Tiotropium | Stiolto | 2023-11-10 | 2015-05-21 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
64%7/11
Phase 3
83%20/24
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use